Skip to search formSkip to main contentSkip to account menu

Remoxipride

Known as: (S)-3-Bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxybenzamide, Remoxipridum, Remoxipride [Chemical/Ingredient] 
An antipsychotic agent that is specific for dopamine D2 receptors. It has been shown to be effective in the treatment of schizophrenia.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2002
Review
2002
  • P. Seeman
  • Canadian journal of psychiatry. Revue canadienne…
  • 2002
  • Corpus ID: 14930109
Background: Al though the prin ci pal brain tar get that all an tipsy chotic drugs at tach to is the do pamine D2 re cep tor, tra… 
Highly Cited
1999
Highly Cited
1999
The objective of this study was to characterize the behavior induced by the N-methyl-D-aspartate receptor antagonist MK-801… 
Highly Cited
1996
Highly Cited
1996
Highly Cited
1994
Highly Cited
1994
Clozapine and haloperidol produce different induction patterns of c-fos expression in the forebrain, with haloperidol increasing…